Evidence map›Paper›PMID 36077402›Full record

ArticleInternational journal of molecular sciences2022

Effective Removal of Methylene Blue on EuVO

Xia Ran, Li Wang, Bo Xiao, Li Lei, Jinming Zhu, Zuoji Liu, Xiaolan Xi, Guangwei Feng, Rong Li, Jian Feng

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Xia RanEngineering Research Center for Molecular Medicine, School of Basic Medical Sciences, Guizhou Medical University, Guiyang 550025, China.
Li WangEngineering Research Center for Molecular Medicine, School of Basic Medical Sciences, Guizhou Medical University, Guiyang 550025, China.
Bo XiaoEngineering Research Center for Molecular Medicine, School of Basic Medical Sciences, Guizhou Medical University, Guiyang 550025, China.
Li LeiEngineering Research Center for Molecular Medicine, School of Basic Medical Sciences, Guizhou Medical University, Guiyang 550025, China.
Jinming ZhuEngineering Research Center for Molecular Medicine, School of Basic Medical Sciences, Guizhou Medical University, Guiyang 550025, China.
Zuoji LiuEngineering Research Center for Molecular Medicine, School of Basic Medical Sciences, Guizhou Medical University, Guiyang 550025, China.
Xiaolan XiEngineering Research Center for Molecular Medicine, School of Basic Medical Sciences, Guizhou Medical University, Guiyang 550025, China.
Guangwei FengEngineering Research Center for Molecular Medicine, School of Basic Medical Sciences, Guizhou Medical University, Guiyang 550025, China.
Rong LiEngineering Research Center for Molecular Medicine, School of Basic Medical Sciences, Guizhou Medical University, Guiyang 550025, China.
Jian FengEngineering Research Center for Molecular Medicine, School of Basic Medical Sciences, Guizhou Medical University, Guiyang 550025, China.ORCID 0000-0002-1404-2354

Funding

Key Project of Basic Research Program of Guizhou Province, China ZK[2021]022National Natural Science Foundation of China 21865006Science and Technology Project of Guizhou Province, China [2018]5779-18, ZK[2021]067
6 · The paper itself

Abstract

In this study, we first manufactured ultrathin g-C

Indexed as

Methylene BlueWater PurificationAdsorptionCatalysisLightMethylene BlueadsorptionEuVO4/g-C3N4 heterojunctionLangmuir isothermmethylene bluephotocatalysis

Identifiers

PMID36077402
PMCPMC9456035

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.